RECHERCHE :   Cancers ORL
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
MK3475-689 : A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
HNSCC Stage III or IVA
III
HUG
CHUV-DO-0018-NeoTIL-2019: Pilot Study to Assess the Feasibility, Safety and Efficacy of Adoptive Transfer of Autologous Tumor-Infiltrating Lymphocytes Enriched for Tumor Antigen Specificity (NeoTIL) in Advanced Solid Tumors.
Tumeurs solides
I
CHUV
NIVO POST-OP: A phase III randomized trial of post-operative adjuvant nivolumab and concomitant chemo-radiotherapy in high-risk patients with resected squamous cell carcinoma of head and neck (SCCHN)
cancer épidermoïde de la tête et du cou localement avancé opéré à risque élevé de récidive
III
CHUV
EORTC 1420 (SAKK 10/16): Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0 oropharyngeal carcinoma
Carcinome épidermoïde oropharyngien (OPSCC)
III
CHUV
SGNB6A-001: A Phase 1 Study of SGN-B6A in Advanced Solid Tumors
NSCLC, HNSCC, ESCC, HGSOC, cSCC, cancer du sein HER2 négative avancé, Adénocarcinome oesophagien/adénocarci-nome gastro-oesophagien, cancer de la vessie, cancer degestif, cancer du col de l'utérus
I
CHUV